These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12533242)

  • 1. New applications of electron diffraction in the pharmaceutical industry: polymorph determination by using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques.
    Li ZG; Harlow RL; Foris CM; Li H; Ma P; Vickery RD; Maurin MB; Toby BH
    Microsc Microanal; 2002 Apr; 8(2):134-8. PubMed ID: 12533242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorph determination for the GP IIb/IIIa antagonist, roxifiban, using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques.
    Li ZG; Harlow RL; Foris CM; Li H; Ma P; Vickery RD; Maurin MB; Toby BH
    J Pharm Sci; 1999 Mar; 88(3):297-301. PubMed ID: 10052986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystalline versus amorphous content of lumaxistrade mark analog XP280 using X-ray and electron diffraction methods.
    Li ZG; Liang L; Harlow RL; Foris CM; Olson RE; Sielecki TM; Liu J; Vickery RD; Maurin MB
    J Pharm Sci; 2000 Oct; 89(10):1237-42. PubMed ID: 10980498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction.
    Egusa K; Okazaki F; Schiewe J; Werthmann U; Wolkenhauer M
    Drugs R D; 2017 Sep; 17(3):413-418. PubMed ID: 28905245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism of roxifiban.
    Maurin MB; Vickery RD; Rabel SR; Rowe SM; Everlof JG; Nemeth GA; Campbell GC; Foris CM
    J Pharm Sci; 2002 Dec; 91(12):2599-604. PubMed ID: 12434404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging identification of polymorphic mixture: Polymorphs I, II and III in olanzapine raw materials.
    Testa CG; Prado LD; Costa RN; Costa ML; Linck YG; Monti GA; Cuffini SL; Rocha HVA
    Int J Pharm; 2019 Feb; 556():125-135. PubMed ID: 30543891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Powder X-Ray Diffraction in Small Molecule Pharmaceuticals: Achievements and Aspirations.
    Thakral NK; Zanon RL; Kelly RC; Thakral S
    J Pharm Sci; 2018 Dec; 107(12):2969-2982. PubMed ID: 30145209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clarithromycin form I determined by synchrotron X-ray powder diffraction.
    Noguchi S; Miura K; Fujiki S; Iwao Y; Itai S
    Acta Crystallogr C; 2012 Feb; 68(Pt 2):o41-4. PubMed ID: 22307251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macromolecular Powder Diffraction: Ready for genuine biological problems.
    Karavassili F; Margiolaki I
    Protein Pept Lett; 2016; 23(3):232-41. PubMed ID: 26786768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of nanostructured lipid carriers using laboratory and synchrotron X-ray scattering and diffraction.
    Tetyczka C; Hodzic A; Kriechbaum M; Juraić K; Spirk C; Hartl S; Pritz E; Leitinger G; Roblegg E
    Eur J Pharm Biopharm; 2019 Jun; 139():153-160. PubMed ID: 30905779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enforcing Ostwald's rule of stages: isolation of paracetamol forms III and II.
    Burley JC; Duer MJ; Stein RS; Vrcelj RM
    Eur J Pharm Sci; 2007 Aug; 31(5):271-6. PubMed ID: 17561383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous Differential Scanning Calorimetry-Synchrotron X-ray Powder Diffraction: A Powerful Technique for Physical Form Characterization in Pharmaceutical Materials.
    Clout A; Buanz AB; Prior TJ; Reinhard C; Wu Y; O'Hare D; Williams GR; Gaisford S
    Anal Chem; 2016 Oct; 88(20):10111-10117. PubMed ID: 27642771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ monitoring of wet granulation using online X-ray powder diffraction.
    Davis TD; Morris KR; Huang H; Peck GE; Stowell JG; Eisenhauer BJ; Hilden JL; Gibson D; Byrn SR
    Pharm Res; 2003 Nov; 20(11):1851-7. PubMed ID: 14661932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of synchrotron X-ray powder diffractometry for detection and quantification of small amounts of crystalline drug substances in pharmaceutical tablets.
    Yamada H; Masuda K; Ishige T; Fujii K; Uekusa H; Miura K; Yonemochi E; Terada K
    J Pharm Biomed Anal; 2011 Sep; 56(2):448-53. PubMed ID: 21703798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchrotron-based X-ray in-situ imaging techniques for advancing the understanding of pharmaceutical granulation.
    Li C; Zhu N; Emady HN; Zhang L
    Int J Pharm; 2019 Dec; 572():118797. PubMed ID: 31678383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple route to full structural analysis of biophosphates and their application to materials discovery.
    Hill MR; Bastow TJ; Bourgeois L; Turner DR; Seeber A; McBean K; Whitfield HJ
    Dalton Trans; 2012 May; 41(18):5497-501. PubMed ID: 22426245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the Stoichiometry of Multicomponent Crystals Using Only X-ray Powder Diffraction Data.
    Maguire CK; Brunskill AP
    Mol Pharm; 2015 Jun; 12(6):2061-7. PubMed ID: 25872584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
    Li Y; Chow PS; Tan RB
    Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural determination of the stable and meta-stable forms of atomoxetine HCl using single crystal and powder X-ray diffraction methods.
    Stephenson GA; Liang C
    J Pharm Sci; 2006 Aug; 95(8):1677-83. PubMed ID: 16732589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.